Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Aug 6;16(1):1478.
doi: 10.1007/s12672-025-03329-x.

Recent advances in calcium peroxide nanomedicines for breast cancer treatment

Affiliations
Review

Recent advances in calcium peroxide nanomedicines for breast cancer treatment

Sirui Hang et al. Discov Oncol. .

Abstract

As a typical solid tumor, breast cancer is characterized by a tumor microenvironment featuring hypoxia, acidosis, and highly reductive conditions. These factors contribute to treatment resistance (e.g., chemoresistance) through various mechanisms, thereby diminishing therapeutic efficacy. Calcium peroxide (CaO2) can generate multiple bioactive molecules (metal ions, H2O2, O2, and OH-) in acidic or neutral environment, making it a promising biomaterial for cancer therapy. Recently, breast cancer has been extensively targeted using CaO2 nanoparticles in both cellular and murine models. In this review, we first provide a summary of strategies employing CaO2 nanomedicine-based breast cancer therapies, then discuss the obstacles and development directions of CaO2 application in breast cancer therapy.

Keywords: Breast cancer; CaO2; Hypoxia; ROS.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval: Not applicable. Consent to participate: Not applicable. Consent to publish: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
The versatility of CaO2 based on chemical reactions

Similar articles

References

    1. Vagia E, Mahalingam D, Cristofanilli M. The landscape of targeted therapies in TNBC. Cancers (Basel). 2020. 10.3390/cancers12040916. - PMC - PubMed
    1. Kim J, Harper A, Mccormack V, Sung H, Houssami N, Morgan E, Mutebi M, Garvey G, Soerjomataram I. Fidler-benaoudia, global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 2025;16:1174. 10.1038/s41591-025-03502-3. - PubMed
    1. Debnath A, Mazumder R. Clinical progress of targeted for breast cancer:a comprehensive review, curr. Cancer Drug Targets. 2025;25:e020424228537. 10.2174/0115680096289260240311062343. - PubMed
    1. Yuan CS, Deng ZW, Qin D, Mu YZ, Chen XG, Liu Y. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: where do we stand? Acta Biomater. 2021;125:1–28. 10.1016/j.actbio.2021.02.030. - PubMed
    1. He C, Zhang S, Liu X, Wang J, Huang Y, Zhang A, Zhang X. CaO2 nanomedicines: a review of their emerging roles in cancer therapy. Nanotechnology. 2023;34:482002. 10.1088/1361-6528/acf381. - PubMed

LinkOut - more resources